ABINGDON, Britain (AP) _ Oxford Immunotec Global PLC (OXFD) on Tuesday reported a loss of $4.9 million in its fourth quarter.
On a per-share basis, the Abingdon, Britain-based company said it had a loss of 22 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
The immunology diagnostics company posted revenue of $23.7 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $23.1 million.
For the year, the company reported that its loss narrowed to $22.3 million, or $1 per share. Revenue was reported as $86.1 million.
For the current quarter ending in April, Oxford Immunotec said it expects revenue in the range of $20.8 million to $21.3 million.
The company expects full-year revenue in the range of $102 million to $105 million.
Oxford Immunotec shares have fallen nearly 10 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.51, a rise of 41 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OXFD at https://www.zacks.com/ap/OXFD
Keywords: Oxford Immunotec, Earnings Report